Safety and tolerability of ultrasmall superparamagnetic iron oxide contrast agent: comprehensive analysis of a clinical development program.
Invest Radiol. 2009 Jun;44(6):336-42. doi: 10.1097/RLI.0b013e3181a0068b.
Invest Radiol. 2009.
PMID: 19661843
Review.